We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHS
3551
Neuberger High Yield Strategies Fund Inc
NHS
$255M
$242K ﹤0.01%
21,172
-1,413
-6% -$15.9K
SPNE
3552
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$242K ﹤0.01%
+19,905
New +$242K
EMBJ
3553
Embraer S.A. ADS
EMBJ
$13.2B
$241K ﹤0.01%
19,106
-58
-0.3% -$823
HYEM icon
3554
VanEck Emerging Markets High Yield Bond ETF
HYEM
$527M
$241K ﹤0.01%
11,946
+1,324
+12% +$27.7K
CBH
3555
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$241K ﹤0.01%
25,834
NEN icon
3556
New England Realty Associates
NEN
$240K ﹤0.01%
3,000
ROG icon
3557
Rogers Corp
ROG
$2.46B
$240K ﹤0.01%
885
BEAM icon
3558
Beam Therapeutics
BEAM
$2.74B
$239K ﹤0.01%
4,163
+1,263
+44% +$82.8K
DMXF icon
3559
iShares ESG Advanced MSCI EAFE ETF
DMXF
$974M
$239K ﹤0.01%
3,922
+675
+21% +$42.8K
AAPL icon
3560
PUT
Apple
AAPL
$4.46T
$238K ﹤0.01%
+66,100
New +$11.1M
CMRC
3561
Commerce.com Inc Series 1
CMRC
$184M
$238K ﹤0.01%
10,848
+5,048
+87% +$135K
RCS
3562
PIMCO Strategic Income Fund
RCS
$249M
$238K ﹤0.01%
40,431
-3,455
-8% -$21.3K
BNDW icon
3563
Vanguard Total World Bond ETF
BNDW
$1.89B
$237K ﹤0.01%
3,203
+7
+0.2% +$532
CB icon
3564
CALL
Chubb
CB
$133B
$237K ﹤0.01%
70,000
+12,900
+23% +$2.62M
REAL icon
3565
The RealReal
REAL
$1.33B
$237K ﹤0.01%
32,692
+22,555
+223% +$200K
OXLC
3566
Oxford Lane Capital
OXLC
$950M
$236K ﹤0.01%
6,507
+1,949
+43% +$74.9K
VREX icon
3567
Varex Imaging
VREX
$780M
$235K ﹤0.01%
+11,042
New +$281K
GTLB icon
3568
GitLab
GTLB
$7.32B
$234K ﹤0.01%
4,289
+1,652
+63% +$98.6K
AVDE icon
3569
Avantis International Equity ETF
AVDE
$18.8B
$233K ﹤0.01%
3,865
+168
+5% +$10.3K
AXSM icon
3570
Axsome Therapeutics
AXSM
$11.2B
$233K ﹤0.01%
5,629
+195
+4% +$6.04K
FOX icon
3571
Fox Class B
FOX
$24.4B
$233K ﹤0.01%
6,436
-338
-5% -$12.6K
APPN icon
3572
Appian
APPN
$2.65B
$232K ﹤0.01%
3,816
+503
+15% +$28.5K
OCFC icon
3573
OceanFirst Financial
OCFC
$1.88B
$232K ﹤0.01%
11,518
-860
-7% -$19.2K
PBT
3574
Permian Basin Royalty Trust
PBT
$1.56B
$232K ﹤0.01%
18,515
+832
+5% +$10.7K
ARDC
3575
Are Dynamic Credit Allocation Fund
ARDC
$298M
$231K ﹤0.01%
15,993

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.